I-Antiretroviral Therapy

I-HIV ne-AIDS yizifo ezingelapheki, kodwa ukuqhubeka kwazo kunganciphisa ngokusebenzisa ukungena kwempilo ekhethekile. Ukwelashwa kwama-antiretroviral ehlanganisiwe kuhilela ukusetshenziswa kwezidakamizwa ezintathu noma ezine kuye ngesigaba sesifo kanye nesilinganiso esivezwe udokotela.

Usebenza kanjani ukwelashwa kwama-antiretroviral?

I-immunodeficiency virus ine-mutagenicity ephezulu. Lokhu kusho ukuthi kuyamelana kakhulu nemiphumela emibi ehlukahlukene futhi uyakwazi ukushintsha i-RNA yayo, ukwakha izinguquko ezintsha ezenzekayo. Le ndawo igxilisa kakhulu ukwelashwa kwe-HIV ne-AIDS, njengoba amangqamuzana e-pathogenic avumelana ngokushesha kakhulu nezidakamizwa ezithathwe.

I-antiretroviral therapy iyinhlanganisela yemithi ehlukene engu-3-4, ngayinye ephethe isimiso esikhethekile sesenzo. Ngakho-ke, ukuthatha izidakamizwa eziningana kunikezela ukucindezelwa hhayi kuphela uhlobo oluyinhloko lwegciwane, kodwa nanoma yikuphi ukuguqulwa kwalo okwakhiwa ngenkathi kuthuthukiswa lesi sifo.

Ngabe i-antiretroviral imithi inikezwe nini?

Ngokwemvelo, ekuqaleni ukwelashwa kokutheleleka nge-HIV kuqala, kungaba ngcono ukuyeka ukuqhubeka kwegciwane, ukuthuthukisa ikhwalithi kanye nokulindela impilo yesiguli. Njengoba kunikezwa ukuthi izimpawu zokuqala zesifo ngokuvamile aziqondakali, ukwelashwa ngezidambisigciwane kumisiwe eminyakeni engama-5-6 emva kokutheleleka, ezimweni ezingavamile le nkathi yanda iminyaka eyi-10.

Izidakamizwa zokwelashwa kwama-antiretroviral kakhulu

Imithi ihlukaniswe ngezigaba:

1. Ama-inhibitors we-reverse transcriptase (i-nucleoside):

2. I-non-nucleoside reverse transcriptase inhibitors:

3. I-protease inhibitors:

Ama-inhibitors we-fusion ayingxenye entsha kunazo zonke yezidakamizwa zokwelashwa okusebenzayo ngezidambisigciwane. Kuze kube manje umuthi owodwa kuphela owaziwa yi-Fuzeon noma i-Enfuvirtide.

Imiphumela emibi ye-antiretroviral therapy

Imiphumela engeyona engozini:

Imiphumela embi: